Cargando…

Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect?

Locoregional treatments (LRT) represent a broad strategy used for reducing the risk of drop-off and contextually improving the survivals in patients with hepatocellular cancer receiving a liver transplantation (LT). However, it is not sufficiently clear if LRT are only a surrogate of tumor aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Quirino, Di Martino, Michele, Lucatelli, Pierleone, Mennini, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102498/ https://www.ncbi.nlm.nih.gov/pubmed/30131653 http://dx.doi.org/10.3748/wjg.v24.i31.3469

Ejemplares similares

A Low Daily Intake of Simple Sugars in the Diet Is Associated with Improved Liver Function in Cirrhotic Liver Transplant Candidates
por: Parisse, Simona, et al.
Publicado: (2023)

Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
por: Vallati, Giulio Eugenio, et al.
Publicado: (2021)

Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients
por: Parisse, Simona, et al.
Publicado: (2021)

Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
por: Vitale, Alessandro, et al.
Publicado: (2021)

Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis
por: Lai, Quirino, et al.
Publicado: (2018)

Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West–East Collaborative Effort
por: Lai, Quirino, et al.
Publicado: (2020)

Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis
por: Lai, Quirino, et al.
Publicado: (2021)

The liver transplant surgeon Mondays blues: an Italian perspective
por: Quaresima, Silvia, et al.
Publicado: (2022)

Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score
por: Lerut, Jan, et al.
Publicado: (2021)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Adult 10-year survivors after liver transplantation: a single-institution experience over 40 years
por: Lai, Quirino, et al.
Publicado: (2023)

Donor-to-recipient gender match in liver transplantation: A systematic review and meta-analysis
por: Lai, Quirino, et al.
Publicado: (2018)

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021)

Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation
por: Ogawa, Kohei, et al.
Publicado: (2022)

CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study
por: Spoletini, Gabriele, et al.
Publicado: (2022)

Downstaging of Hepatocellular Carcinoma Prior to Liver Transplant: Is There a Role for Adjuvant Sorafenib in Locoregional Therapy?
por: Vagefi, Parsia A., et al.
Publicado: (2010)

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
por: Yoo, Eun Jin, et al.
Publicado: (2013)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021)

Microballoon Interventions for Liver Tumors: Review of Literature and Future Perspectives
por: Lucatelli, Pierleone, et al.
Publicado: (2022)

Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation
por: Lai, Quirino, et al.
Publicado: (2022)

Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019)

Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy
por: Parisse, Simona, et al.
Publicado: (2023)

Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review
por: Lai, Quirino, et al.
Publicado: (2020)

Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis
por: Golfieri, Rita, et al.
Publicado: (2021)

Postoperative Trends and Prognostic Values of Inflammatory and Nutritional Biomarkers after Liver Transplantation for Hepatocellular Carcinoma
por: Pravisani, Riccardo, et al.
Publicado: (2021)

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
por: Amado, Víctor, et al.
Publicado: (2018)

COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL
por: de FREITAS, Alexandre Coutinho Teixeira, et al.
Publicado: (2016)

Magnetic Resonance Imaging Predictors of Hepatocellular Carcinoma Progression and Dropout in Patients in Liver Transplantation Waiting List
por: Baghdadi, Azarakhsh, et al.
Publicado: (2022)

Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change
por: Saberi, Behnam, et al.
Publicado: (2023)

New Insights in the Setting of Transplant Oncology
por: Quaresima, Silvia, et al.
Publicado: (2023)

End-stage renal disease is a risk factor for complex laparoscopic cholecystectomy in patients waiting for renal transplantation
por: Colozzi, Sara, et al.
Publicado: (2019)

Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List
por: Miles, Clifford D., et al.
Publicado: (2018)

The impact of mini-invasive right hepatectomy in the setting of living donation: a meta-analysis
por: Lai, Quirino, et al.
Publicado: (2021)

HYPOXIA AMONG PATIENTS ON THE LIVER-TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2014)

IMPACT OF MELD SODIUM ON LIVER TRANSPLANTATION WAITING LIST
por: de FREITAS, Alexandre Coutinho Teixeira, et al.
Publicado: (2019)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results
por: Lucatelli, Pierleone, et al.
Publicado: (2019)

The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
por: Wang, Qi, et al.
Publicado: (2022)

Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
por: Györi, Georg P., et al.
Publicado: (2017)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjl2i1j49m3j25mtl66j8qrjks